SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

NVIDIA Corp. engages in the design and manufacture of computer graphics processors, chipsets, and related multimedia software. It operates through the following segments: Graphics Processing Unit (GPU) and Compute & Networking. The Graphics segment includes GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, Quadro and NVIDIA RTX GPUs for enterprise workstation graphics, virtual GPU, or vGPU, software for cloud-based visual and virtual computing, automotive platforms for infotainment systems, and Omniverse Enterprise software for building and operating metaverse and 3D internet applications. The Compute & Networking segment consists of Data Center accelerated computing platforms and end-to-end networking platforms including Quantum for InfiniBand and Spectrum for Ethernet, NVIDIA DRIVE automated-driving platform and automotive development agreements, Jetson robotics and other embedded platforms, NVIDIA AI Enterprise and other software, and DGX Cloud software and services. The company was founded by Jen Hsun Huang, Chris A. Malachowsky, and Curtis R. Priem in April 1993 and is headquartered in Santa Clara, CA.

NVIDIA Corp

NVIDIA is trending following an earnings report that eased AI bubble fears and showcased strong revenue growth, particularly in its data center segment. The community is debating the sustainability of this growth, questioning accounting practices and revenue recognition, while also anticipating potential impact from a White House request regarding chip exports to China. Bullish sentiment prevails, with some analysts predicting further climbs, while others remain cautious, citing macro risks.

RAGE GUY (RAGE) is a cryptocurrency inspired by the Rage Guy meme, one of the earliest and most recognizable characters from internet rage comics. The project captures the cultural legacy of early meme history and brings it onto the blockchain in tokenized form. It is designed as a community-driven digital asset that celebrates internet culture, nostalgia, and the role memes play in shaping online communities.

Rage Guy

RAGE CRYPTO is gaining traction as community members rally around the revival of OG memes and a shared vision for the project's future. There's excitement around the strong community being built and references to the potential for significant growth, with many expressing long-term bullish sentiment. The community emphasizes building, grinding, and continuing to work even during red days.

GeneDx Holdings Corp. operates as a health intelligence company. It engages in healthcare with the use of its collected disease data sets. It offers exome and genome testing for diagnosis of genetic disease. The company was founded by Eric Schadt in October 2015 and is headquartered in Stamford, CT.

GeneDx Holdings Corp - Ordinary Shares - Class A

GeneDx Holdings Corp

GeneDx is trending as community members assess the impact of new coverage from Piper Sandler and Canaccord Genuity, with price targets ranging from $155-$160. Recent news and strong earnings have generated discussion around the company's growth potential and possible disruptor status, while some traders are closely watching the chart setup for potential breakout opportunities and technical brilliance. Meanwhile, other investors are evaluating its high valuation and potential issues related to profitability and Medicaid.

Agios Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in a research engine, multiple novels, and investigational therapies in preclinical development. It focuses on cellular metabolism and classical hematology. The company was founded by Lewis Clayton Cantley, Tak W. Mak, Craig B. Thompson and Shin-Shan Michael Su on August 7, 2007 and is headquartered in Cambridge, MA.

Agios Pharmaceuticals Inc

Agios Pharmaceuticals ($AGIO) is trending downwards after mixed results from its sickle cell disease drug trial sparked uncertainty about its regulatory path, leading to a significant stock plunge. Bullish analysts are split with some citing precedent for FDA approval, while the community debates the impact of missed endpoints and considers potential opportunities for competitors. Discussions also involve the company's cash position and upcoming PDUFA date for thalassemia.

Oracle Corp. engages in the provision of products and services that address aspects of corporate information technology environments, including applications and infrastructure technologies. It operates through the following business segments: Cloud and License, Hardware, and Services. The Cloud and License segment markets, sells, and delivers enterprise applications and infrastructure technologies through cloud and on-premise deployment models including cloud services and license support offerings. The Hardware segment provides infrastructure technologies including Oracle Engineered Systems, servers, storage, industry-specific hardware, operating systems, virtualization, management, and other hardware-related software. The Services segment offers consulting, advanced support, and education services. The company was founded by Lawrence Joseph Ellison, Robert Nimrod Miner, and Edward A. Oates on June 16, 1977 and is headquartered in Austin, TX.

Oracle Corp.

ORCL is trending amid discussions about AI infrastructure spending and concerns over debt, sparked by analyst commentary and comparisons to historical market bubbles. Community members are debating the impact of potential government involvement and upcoming earnings, while also scrutinizing insider trading activity and the company's response to market pressures. Some traders anticipate a rebound, while others remain bearish, citing technical indicators and valuation concerns.

SSgA Active Trust - SPDR Dow Jones Industrial Average ETF

DIA is trending as investors monitor factors including the potential end of the government shutdown and its impact on economic data. Community discussions revolve around market volatility and possible opportunities in sectors like healthcare, with some expressing caution about an overvalued market. Nvidia's potential influence and the Federal Reserve's upcoming decisions are also key talking points.

ETF Opportunities Trust - T-Rex 2X Long NVIDIA Daily Target ETF

T-Rex 2X Long NVIDIA Daily Target ETF

T-Rex 2X Long NVIDIA Daily Target ETF ($NVDX) is trending amid discussions around NVIDIA's earnings and its impact on the AI ecosystem. The community is actively analyzing earnings results, strategizing trades with leveraged ETFs, and debating future movements. Bullish sentiment is fueled by confidence in NVIDIA's long-term growth and dominance in the AI sector, while some traders express caution regarding the ETF's decay and potential market volatility.

GraniteShares ETF Trust - GraniteShares 2x Long NVDA Daily ETF

GraniteShares 2x Long NVDA Daily ETF

GraniteShares 2x Long NVDA Daily ETF (NVDL) is trending as traders analyze the potential impact of recent news on NVDA's earnings and future growth. The community is actively discussing strategies using leveraged ETFs to capitalize on potential after-hours moves and overall market sentiment around AI and semiconductor stocks. Some traders express bullish sentiment, anticipating a gap up after earnings, while others are cautious, considering potential pullbacks and hedging their positions.

Super Micro Computer, Inc. engages in the distribution and manufacture of information technology solutions and other computer products. Its products include twin solutions, MP servers, GPU and coprocessor, MicroCloud, AMD solutions, power supplies, SuperServer, storage, motherboards, chassis, super workstations, accessories, SuperRack and server management products. The company was founded by Charles Liang, Yih-Shyan Liaw, Sara Liu, and Chiu-Chu Liu Liang in September 1993 and is headquartered in San Jose, CA.

Super Micro Computer Inc

SMCI is trending as investors debate its future amid discussions about AI infrastructure and Nvidia's role, with some community members pointing to a low P/S ratio as a sign of undervaluation. Bearish sentiment and concerns over margins are also circulating, contrasting with bullish arguments centered on the company's growth potential in the AI sector. Recent news of Nvidia partnerships and increased AI spending in Saudi Arabia are adding to the discussions around SMCI's prospects.

Safe & Green Holdings Corp. is a design and construction services company, which engages in the provision of code engineered cargo shipping containers. It operates through the following segments: Construction, Medical, Development, and Corporate and Support. The Construction Services segment includes the manufacturing of unit SG ECHO and other modules projects. The Medical segment consists of joint venture COVID-19 laboratory operations. The Development segment focuses on real property development. The Corporate and Support segment includes general corporate expenses such as the executive office, corporate finance, accounting, audit, tax, human resources, risk management, information technology, marketing, and legal groups, corporate overhead, and other items not allocated to any of the company's other segments. The company was founded on December 29, 1993 and is headquartered in Miami, FL.

Safe & Green Holdings Corp

Safe & Green Holdings is experiencing high volatility as traders discuss a potential short squeeze, citing a low float and significant short interest. Community members are actively tracking volume and VWAP, anticipating a breakout and comparing the situation to previous meme stock rallies. The stock's movement is also linked to upcoming corporate events, with some traders setting price targets based on these potential catalysts.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Gyre Therapeutics, Inc. (NASDAQ:GYRE) Receives Average Rating of "Hold" from Brokerages

Shares of Gyre Therapeutics, Inc. (NASDAQ:GYRE - Get Free Report) have received a consensus recommendation of "Hold" from the five ratings firms that are currently covering the stock, MarketBeat...

Gyre Therapeutics (NASDAQ:GYRE) Stock Rating Upgraded by Wall Street Zen

Wall Street Zen raised shares of Gyre Therapeutics from a "hold" rating to a "buy" rating in a report on Saturday...

SBI Securities Co. Ltd. Purchases 108,670 Shares of Gyre Therapeutics, Inc. $GYRE

SBI Securities Co. Ltd. increased its holdings in Gyre Therapeutics, Inc. (NASDAQ:GYRE - Free Report) by 87.9% during the second quarter, according to its most recent disclosure with the SEC. The...

Noble Financial Has Bearish Estimate for GYRE Q1 Earnings

Gyre Therapeutics, Inc. (NASDAQ:GYRE - Free Report) - Equities research analysts at Noble Financial dropped their Q1 2026 earnings per share (EPS) estimates for Gyre Therapeutics in a research note...

Research Analysts Offer Predictions for GYRE FY2025 Earnings

Gyre Therapeutics, Inc. (NASDAQ:GYRE - Free Report) - Stock analysts at HC Wainwright boosted their FY2025 earnings per share (EPS) estimates for shares of Gyre Therapeutics in a research report...

GYRE THERAPEUTICS, INC. Announces Advance In Q3 Income

(RTTNews) - GYRE THERAPEUTICS, INC. (GYRE) reported a profit for its third quarter that Increased, from the same period last year...

Gyre Therapeutics, Inc. (GYRE) Q3 Earnings Surpass Estimates

Gyre Therapeutics, Inc. (GYRE) delivered earnings and revenue surprises of +20.00% and -8.89%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?

Guardant Health (GH) Reports Q3 Loss, Beats Revenue Estimates

Guardant Health (GH) delivered earnings and revenue surprises of +18.75% and +13.05%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?

New Strong Sell Stocks for Oct. 17th

GYRE, DAR and CRLBF have been added to the Zacks Rank #5 (Strong Sell) List on October 17, 2025.

Strength Seen in Septerna, Inc. (SEPN): Can Its 7.0% Jump Turn into More Strength?

Septerna, Inc. (SEPN) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.

Gyre Therapeutics, Inc. operates as a biopharmaceutical company. It is focused on the development and commercialization of Hydronidone (F351) for the treatment of Metabolic Dysfunction Associated Steatohepatitis (MASH-associated liver fibrosis). The firm operates through the BC and Gyre segments. The company was founded on March 7, 1997 and is headquartered in San Diego, CA.

Current Price	$7.57
Prev Close	$7.67
Open	$7.61
Dividend Yield	0.00%
50-Day Moving Average	$7.74
Beta	1.37
Avg. Volume	83,738.87
PE Ratio	198.69

52-Week High	$14.42
52-Week Low	$6.11
Market Capitalization	$738.88M
EPS (Annual)	$0.0481
Price to Book	6.75
Revenue Per Employee	$21.15M
Enterprise Value/EBITDA	N/A

GYRE
Gyre Therapeutics Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest GYRE News

GYREGyre Therapeutics Inc